TrademarkDir
N NUCARE PHARMACEUTICALS, INC.
LIVE

Serial Number

85230074

Owner

NUCARE PHARMACEUTICALS, Inc.

Attorney

Amanda V. Dwight

First Use Date

Jan 16, 2001

Filing Date

Jan 31, 2011

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

N NUCARE PHARMACEUTICALS, INC. Trademark

Serial Number: 85230074 • Registration: 4098137

N NUCARE PHARMACEUTICALS, INC. is a trademark filed by NUCARE PHARMACEUTICALS, Inc. on January 31, 2011. The trademark is classified under Class 39 (Transportation & Storage), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

NUCARE PHARMACEUTICALS, Inc. (2 trademarks)

ORANGE, CA 92867

Entity Type: 03

Trademark Details

Filing Date

January 31, 2011

Registration Date

February 14, 2012

First Use Anywhere

January 16, 2001

First Use in Commerce

February 16, 2001

Published for Opposition

November 29, 2011

Goods & Services

Packaging pharmaceuticals and health care products to the order and specification of others

Business services for others in the health care field, namely, computerized on-line ordering to replenish drugs for pharmacies and medication dispensing machines; computerized database management in the field of pharmaceutical lot number and expiration dating; sales volume tracking; distributorship services featuring prepackaged pharmaceuticals and supplies

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jun 24, 2021 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jun 24, 2021 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jun 24, 2021 89AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jun 22, 2021 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Jun 19, 2021 PR89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 19, 2021 APRE
TEAS SECTION 8 & 9 RECEIVED
Mar 17, 2021 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 14, 2021 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 9, 2017 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 9, 2017 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 9, 2017 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 17, 2017 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 14, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 14, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 29, 2011 NPUB
PUBLISHED FOR OPPOSITION
Nov 29, 2011 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 9, 2011 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 26, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2011 CNSA
DATA MODIFICATION COMPLETED
Oct 20, 2011 DMCC
ASSIGNED TO LIE
Oct 14, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 6, 2011 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 6, 2011 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 3, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 3, 2011 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2011 GNRN
NON-FINAL ACTION E-MAILED
Apr 28, 2011 GNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2011 CNRT
ASSIGNED TO EXAMINER
Apr 28, 2011 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Feb 5, 2011 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 4, 2011 NWOS
NEW APPLICATION ENTERED
Feb 3, 2011 NWAP

Related Trademarks

More from this Owner

NUCARE PHARMACEUTICALS, INC.

NUCARE PHARMACEUTICALS, INC.

NUCARE PHARMACEUTICALS, INC.

NUCARE PHARMACEUTICALS, INC.

NUCARE PHARMACEUTICALS, INC.

NUCARE PHARMACEUTICALS, INC.